Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
06/1999
06/16/1999CN1219936A New triazolopurines, method of preparing them and their use as drugs
06/10/1999WO1999028342A2 Low-voltage activated calcium channel compositions and methods
06/10/1999WO1999028337A1 15-methyl-cyclopropanosteroids and method for the production thereof
06/10/1999WO1999028300A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
06/10/1999WO1999027936A1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
06/10/1999WO1999027897A1 Site-specific preparation of polyethylene glycol-grf conjugates
06/10/1999DE19753363A1 15-Methyl-cyclopropanosteroide und Verfahren zu ihrer Herstellung 15-methyl-cyclopropanosteroide and processes for their preparation
06/10/1999CA2312334A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
06/10/1999CA2312195A1 Low-voltage activated calcium channel compositions and methods
06/09/1999EP0921130A2 Steroid sulphatase inhibitors
06/09/1999EP0920863A1 2-Aryl-3-aroylbenzo(b)thiophenes useful for the treatment of estrogen deprivation syndrome
06/09/1999EP0920862A1 2-Arylbenzo b thiophenes useful for the treatment of estrogen deprivation syndrome
06/09/1999EP0920504A2 Voltage-gated calcium channel antagonist and methods
06/09/1999EP0920446A1 Conformationally constrained backbone cyclized somatostatin analogs
06/09/1999EP0920441A1 7alpha-(epsilon-aminoalkyl)-estratrienes, process for preparing the same, pharmaceutical preparations containing said 7alpha-(epsilon-aminoalkyl)-estratrienes and their use for preparing medicament
06/09/1999EP0920438A2 N6 heterocyclic substituted adenosine derivatives
06/09/1999EP0920429A1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
06/09/1999EP0920319A1 Antagonists of gonadotropin releasing hormone
06/08/1999US5910497 Treating acne vulgaris
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999026962A1 Androgenic steroid compounds and a method of making and using the same
06/03/1999CA2311448A1 Androgenic steroid compounds and a method of making and using the same
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/02/1999EP0918774A1 Androgen receptor modulator compounds and methods
06/02/1999EP0918759A1 Novel thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same
06/02/1999EP0918522A1 Antagonists of gonadotropin releasing hormone
06/02/1999EP0918455A1 Galanin
06/02/1999EP0593692B1 Process for the preparation of ergoline derivatives
06/02/1999CN1218402A Improvement of implantation rates after vitro fertilization
05/1999
05/27/1999WO1999025725A1 NOVEL 19-NOR STEROIDS SUBSTITUTED IN POSITION 11β, PREPARATION METHOD AND INTERMEDIATES, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
05/27/1999WO1999025707A1 2-ARYLBENZO[b]THIOPHENES USEFUL FOR THE TREATMENT OF ESTROGEN DEPRIVATION SYNDROME
05/27/1999WO1999025706A1 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome
05/27/1999WO1999025359A1 New composition of matter
05/27/1999WO1999012961A8 Estrogen receptor
05/27/1999WO1999012529A3 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
05/27/1999CA2309859A1 2-arylbenzo¬b|thiophenes useful for the treatment of estrogen deprivation syndrome
05/27/1999CA2309824A1 2-aryl-3-aroylbenzo¬b|thiophenes useful for the treatment of estrogen deprivation syndrome
05/27/1999CA2309242A1 Novel 19-nor steroids substituted in position 11.beta., preparation method and intermediates, application as medicines and pharmaceutical compositions containing them
05/26/1999EP0917572A2 Secreted proteins and polynucleotides encoding them
05/26/1999CN1217719A Novel benzofuranone derivative and process for producing same
05/25/1999CA2011452C Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7–,17–)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn -3-one
05/20/1999WO1999024042A2 Stable antiandrogenic gel composition
05/20/1999CA2309123A1 Stable antiandrogenic gel composition
05/19/1999EP0916345A1 Remedies for eating disturbance
05/19/1999EP0915876A1 Tricyclic benzazepine vasopressin antagonists
05/18/1999US5904931 Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide
05/14/1999WO1999022729A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
05/14/1999WO1999001467A3 Therapeutically active compounds with low systemic activity due to reduce half life
05/12/1999EP0914334A1 Process and intermediates for the synthesis of lhrh antagonists
05/12/1999EP0914148A1 Treatment of partial growth hormone insensitivity syndrome
05/12/1999CN1216537A Compounds with growth hormone releasing properties
05/12/1999CN1216472A A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
05/06/1999WO1999022243A1 148 human secreted proteins
05/06/1999WO1999021888A1 Aggregates of human insulin derivatives
05/06/1999WO1999021857A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
05/06/1999WO1999021617A2 Allosteric adenosine receptor modulators
05/06/1999WO1999021567A1 Pharmaceutical compositions for oral administration of molecular iodine
05/06/1999WO1999021546A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS
05/06/1999EP0912741A2 T-cell selective interleukin-4 agonists
05/06/1999EP0912731A2 Secreted proteins
05/06/1999EP0912602A1 Method of treating beta-amyloid peptide associated conditions using trh
05/06/1999EP0912601A1 Suppression of immune response via inhibition of cathepsin s
05/06/1999EP0912551A1 Somatostatin agonists and antagonists
05/06/1999EP0912542A1 Oxocoumarin and barbituric acid derivates, their preparation and their use as ligand inhibitors of a corticotropin-releasing factor (crf) and/or a crf-binding protein complex
05/06/1999EP0912186A1 Progestogen-anti-progestogen regimens
05/06/1999EP0912185A1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
05/06/1999EP0883596A4 Fluorinated propranolol and related methods
05/06/1999EP0785792B1 Treatment of ovarian estrogen dependent conditions
05/06/1999CA2309135A1 N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors
05/06/1999CA2308705A1 Aggregates of human insulin derivatives
05/06/1999CA2307320A1 148 human secreted proteins
05/06/1999CA2305258A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
05/05/1999CN1216043A Substd. benzenesulfonamide derivs as prodrugs of COX-2 inhibitors
04/1999
04/30/1999CA2219867A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
04/29/1999WO1999020292A1 Pharmaceutical grade ginseng
04/29/1999WO1999020282A1 Progestin therapy with controlled bleeding
04/29/1999DE19747063A1 New 3-substituted tetrahydropyridopyrimidinone derivatives
04/29/1999CA2649671A1 Progestin therapy for causing endometrial atrophy while maintaining amenorrhea
04/29/1999CA2307615A1 Progestin therapy with controlled bleeding
04/29/1999CA2307047A1 Pharmaceutical grade ginseng
04/28/1999EP0910579A1 Compounds with growth hormone releasing properties
04/28/1999EP0650359B1 Transdermal therapeutic system containing the active substance 17- -oestradiol (anhydrous)
04/28/1999CN1214933A Medicine for curing hyperthyroidism
04/28/1999CN1214910A Pharmaceutical application of crust holoside and derivant thereof
04/27/1999US5898030 hGH containing pharmaceutical compositions
04/27/1999CA2163778C Indole derivatives as steroid 5a-reductase inhibitors
04/22/1999WO1999019354A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
04/22/1999WO1999019351A1 Novel npy family member
04/22/1999WO1999019313A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
04/22/1999WO1999019293A1 Novel aryloxy-alkyl-dialkylamines
04/22/1999WO1999018932A1 Novel once-a-day controlled release sulfonylurea formulation
04/22/1999CA2308009A1 Novel npy family member
04/22/1999CA2306453A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
04/21/1999EP0909171A1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1
04/21/1999CN1214633A Stabilised growth hormone formulation and method of preparation thereof
04/15/1999WO1999018101A1 Benzothiophenes
04/15/1999WO1999018081A1 Substituted fused heterocyclic compounds
04/15/1999WO1999018075A1 Novel dihydronaphthalene compounds and process for producing the same
04/15/1999WO1999018070A1 Novel vitamin d analogues
04/15/1999WO1999017712A2 Tightening and/or reducing the size of body parts containing fat cells
1 ... 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 ... 290